Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

# AGENCY:

Presidential Commission for the Study of Bioethical Issues, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.

# ACTION:

Notice of Meeting.

# SUMMARY:

The Presidential Commission for the Study of Bioethical Issues (the Commission) will conduct its nineteenth meeting on November 5-6, 2014. At this meeting, the Commission will conclude discussions related to the BRAIN Initiative and ongoing work in neuroscience, and begin discussions about the role of deliberation and education in bioethics.

# DATES:

The meeting will take place Wednesday, November 5, 2014, from 9 a.m. to approximately 5 p.m., and Thursday, November 6, 2014, from 9 a.m. to approximately 1p.m.

# ADDRESSES:

Radisson Hotel Salt Lake City Downtown, 215 W. South Temple, Salt Lake City, UT 84101.

# FOR FURTHER INFORMATION CONTACT:

                        Hillary Wicai Viers, Communications Director, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Telephone: 202-233-3960. Email:                         *Hillary.Viers@bioethics.gov.*                         Additional information may be obtained at                         *www.bioethics.gov.*

# SUPPLEMENTARY INFORMATION:

                    Pursuant to the Federal Advisory Committee Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given of the nineteenth meeting of the Commission. The meeting will be open to the public with attendance limited to space available. The meeting will also be webcast at                     *www.bioethics.gov.*

Under Executive Order 13521, dated November 24, 2009, the President gave authority for the establishment of the Commission. The Commission is an expert panel of not more than 13 members who are drawn from the fields of bioethics, science, medicine, technology, engineering, law, philosophy, theology, or other areas of the humanities or social sciences. The Commission advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. The Commission seeks to identify and promote policies and practices that ensure scientific research, health care delivery, and technological innovation are conducted in a socially and ethically responsible manner.

The main agenda items for the Commission's nineteenth meeting are to discuss the BRAIN Initiative and ongoing work in neuroscience, and the role of deliberation and education in bioethics.

                    The draft meeting agenda and other information about the Commission, including information about access to the webcast, will be available at                     *www.bioethics.gov.*

                    The Commission welcomes input from anyone wishing to provide public comment on any issue before it. Respectful debate of opposing views and active participation by citizens in public exchange of ideas enhances overall public understanding of the issues at hand and conclusions reached by the Commission. The Commission is particularly interested in receiving comments and questions during the meeting that are responsive to specific sessions. Written comments will be accepted at the registration desk and comment forms will be provided to members of the public in order to write down questions and comments for the Commission as they arise. To accommodate as many individuals as possible, the time for each question or comment may be limited. If the number of individuals wishing to pose a question or make a comment is greater than can reasonably be accommodated during the scheduled meeting, the Commission may make a random selection.                          ( print page 61642)    

                    Written comments will also be accepted in advance of the meeting and are especially welcome. Please address written comments by email to                     *info@bioethics.gov,*                     or by mail to the following address: Public Commentary, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Comments will be publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted.                

                    Anyone planning to attend the meeting who needs special assistance, such as sign language interpretation or other reasonable accommodations, should notify Esther Yoo by telephone at (202) 233-3960, or email at                     *Esther.Yoo@bioethics.gov*                     in advance of the meeting. The Commission will make every effort to accommodate persons who need special assistance.                

Dated: October 1, 2014.

Lisa M. Lee,

Executive Director, Presidential Commission for the Study of Bioethical Issues.

[FR Doc. 2014-24334 Filed 10-10-14; 8:45 am]

BILLING CODE 4154-06-P